Monthly Archives: September 2014

Patients with advanced, incurable cancer denied palliative care

Many patients with advanced, incurable cancer do not receive any palliative care, reveals new research to be presented later this month at the ESMO 2014 Congress in Madrid, Spain, 26-30 September. The findings are astonishing as they come at the … Continue reading

Posted in Presentation | Tagged , , | Leave a comment

EMAS publishes position statement on breast cancer screening in Elsevier journal Maturitas

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of breast cancer screening. Breast cancer … Continue reading

Posted in General | Tagged , , | Leave a comment

Wild berry extract may strengthen effectiveness of pancreatic cancer drug

Worth considering micronutrient and drug combo for hard to treat cancers, say researchers The findings prompt the researchers to suggest that adding ‘nutraceuticals’ to chemotherapy cycles may improve the effectiveness of conventional drugs, particularly in hard to treat cancers, such … Continue reading

Posted in Research | Tagged , , , | Leave a comment

Many patients in cancer centers may not experience a dignified death

A new study that surveyed physicians and nurses in hospitals within cancer centers in Germany suggests that many patients there do not experience a dignified death. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study … Continue reading

Posted in Research | Tagged , , , | Leave a comment

New antifungal as effective as existing drugs with fewer adverse events

A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and … Continue reading

Posted in Presentation | Tagged , , , , , , | Leave a comment

Novel immunotherapy vaccine decreases recurrence in HER2 positive breast cancer patients

Women who received trastuzumab, Herceptin, as part of standard treatment show greatest benefit A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients … Continue reading

Posted in Presentation | Tagged , , , , , | Leave a comment